Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.

Background: Optimal treatment of in-stent restenosis (ISR) remains uncertain in the era of drug-eluting stents (DES). This study aims to determine contemporary treatment of ISR and to assess recurrent ISR rates in the era of DES.

Methods: We examined 60 patients presenting for treatment of ISR (one lesion per patient) who were enrolled in the Melbourne Interventional Group Registry (4% of total population of 1423 patients) between April 2004 and January 2005.

Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction? A multicentre study.

Objective: To evaluate the use of cardiovascular medications in patients with and without heart failure after myocardial infarction (MI).

Design And Setting: Multicentre study of drug therapy for patients with MI in 16 major metropolitan teaching hospitals in Australia over a 1-month period at each hospital in the period November 2004 - March 2005.

Participants: 479 patients admitted consecutively to the individual hospitals.